Welcome to Critical Mass, Law.com’s new briefing on class actions and mass torts. I’m Amanda Bronstad in Los Angeles. Talc plaintiffs are turning to an appeals court to revive a class action against Johnson & Johnson – while also prepping for a second trial tying baby powder to mesothelioma. Also, find out why this objector lawyer thinks a $130 million class action settlement with Citibank is too low. And the MDL panel’s hearing this week in Miami includes dockets over diabetes and dicamba.

Send your feedback to [email protected] or find me on Twitter: @abronstadlaw

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]